These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1283572)

  • 1. Vascular calcium overload. Physiological and pharmacological consequences.
    Atkinson J
    Drugs; 1992; 44 Suppl 1():111-8. PubMed ID: 1283572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Ca overload produced by vitamin D3 plus nicotine diminishes arterial distensibility in rats.
    Atkinson J; Poitevin P; Chillon JM; Lartaud I; Levy B
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H540-7. PubMed ID: 8141355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic effects of a new dihydropyridine calcium entry blocker, S-12968-(-), in a rat model of cardiovascular calcium overload.
    Makki T; Lartaud I; Bray-des Boscs L; Capdeville-Atkinson C; Chillon JM; Hoffman M; Nicolas JP; Atkinson J
    Br J Pharmacol; 1992 May; 106(1):79-84. PubMed ID: 1324069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular calcium overload produced by administration of vitamin D3 and nicotine in rats. Changes in tissue calcium levels, blood pressure, and pressor responses to electrical stimulation or norepinephrine in vivo.
    Thorin E; Henrion D; Oster L; Thorin-Trescases N; Capdeville C; Martin JA; Chillon JM; Hicks PE; Atkinson J
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):257-66. PubMed ID: 1697382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The consequences of aortic calcium overload following vitamin D3 plus nicotine treatment in young rats.
    Henrion D; Chillon JM; Godeau G; Muller F; Capdeville-Atkinson C; Hoffman M; Atkinson J
    J Hypertens; 1991 Oct; 9(10):919-26. PubMed ID: 1658134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic treatment with the calcium entry blocker, isradipine, on vascular calcium overload produced by vitamin D3 and nicotine in rats.
    Henrion D; Chillon JM; Capdeville-Atkinson C; Atkinson J
    J Pharmacol Exp Ther; 1992 Jan; 260(1):1-8. PubMed ID: 1309868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related arterial calcification in rats.
    Kieffer P; Robert A; Capdeville-Atkinson C; Atkinson J; Lartaud-Idjouadiene I
    Life Sci; 2000 May; 66(24):2371-81. PubMed ID: 10864099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in endothelium-dependent relaxation in the mesenteric arterial bed following vascular calcium overload produced by vitamin D3 and nicotine in rats.
    Henrion D; Chillon JM; Hoffman M; Capdeville-Atkinson C; Atkinson J
    Life Sci; 1991; 49(8):575-86. PubMed ID: 1650877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium overload--an important cellular mechanism in hypertension and arteriosclerosis.
    Fleckenstein-Grün G; Frey M; Thimm F; Hofgärtner W; Fleckenstein A
    Drugs; 1992; 44 Suppl 1():23-30. PubMed ID: 1283581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of age on vascular calcification induced by vitamin D3 and nicotine].
    Shi Y; Zhou YB; Cai Y; Teng X; Song JQ; Duan XH; Zhang WZ; Qi YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 42(2):131-6. PubMed ID: 20396349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations.
    Fleckenstein-Grün G; Thimm F; Czirfuzs A; Matyas S; Frey M
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S75-84. PubMed ID: 7898099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular calcium overload produced by vitamin D3, in rats. Effect of treatment with SR 33805, a novel calcium entry blocker.
    Chatelain P; Mouton J; Feys G; Laruel A; Manning AS
    Cardiovasc Res; 1995 Dec; 30(6):1038-43. PubMed ID: 8746222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic calcification produced by vitamin D3 plus nicotine.
    Niederhoffer N; Bobryshev YV; Lartaud-Idjouadiene I; Giummelly P; Atkinson J
    J Vasc Res; 1997; 34(5):386-98. PubMed ID: 9349732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium--a neglected key factor in arteriosclerosis. The pathogenic role of arterial calcium overload and its prevention by calcium antagonists.
    Fleckenstein-Grün G; Fleckenstein A
    Ann Med; 1991; 23(5):589-99. PubMed ID: 1756029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac function in a rat model of chronic aortic stiffness.
    Lartaud-Idjouadiene I; Niederhoffer N; Debets JJ; Struyker-Boudier HA; Atkinson J; Smits JF
    Am J Physiol; 1997 May; 272(5 Pt 2):H2211-8. PubMed ID: 9176288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arteriosclerosis and calcification.
    Dobrowolski LA
    G Gerontol; 1971 Aug; 19(8):552-7. PubMed ID: 4334760
    [No Abstract]   [Full Text] [Related]  

  • 17. Differentiation between calcium- and cholesterol-dominated types of arteriosclerotic lesions: antiarteriosclerotic aspects of calcium antagonists.
    Fleckenstein-Grün G; Frey M; Thimm F; Luley C; Czirfusz A; Fleckenstein A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S1-9. PubMed ID: 1725909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antihypertensives on calcium kinetics in the aorta of spontaneously hypertensive rats.
    Zsotér TT; Wolchinsky C
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):287-93. PubMed ID: 708155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium metabolism and structure in the peripheral vasculature: implications for hypertension.
    Mulvany MJ; Aalkjaer C
    J Cardiovasc Pharmacol; 1988; 12 Suppl 5():S134-8. PubMed ID: 2469872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular signal transduction and atherosclerosis.
    Smirnov VN; Voyno-Yasenetskaya TA; Antonov AS; Lukashev ME; Shirinsky VP; Tertov VV; Tkachuk VA
    Ann N Y Acad Sci; 1990; 598():167-81. PubMed ID: 2248435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.